| Stage | OTEX | % of rev | LDOS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.3B | 100.00% | $4.6B | 100.00% | LDOS ×3.38 |
| Gross profit | $1.0B | 74.98% | $817M | 17.92% | OTEX +57.1pp |
| Operating income | $320M | 23.70% | $514M | 11.28% | OTEX +12.4pp |
| Pre-tax income | $251M | 18.57% | $451M | 9.89% | OTEX +8.7pp |
| Net income | $156M | 11.54% | $356M | 7.81% | OTEX +3.7pp |
| Stage | OTEX | LDOS | Gap · A − B |
|---|---|---|---|
| Revenue | $1.3B100.00% | $4.6B100.00% | LDOS ×3.38 |
| Gross profit | 74.98%$1.0B | 17.92%$817M | OTEX +57.1pp |
| Operating income | 23.70%$320M | 11.28%$514M | OTEX +12.4pp |
| Pre-tax income | 18.57%$251M | 9.89%$451M | OTEX +8.7pp |
| Net income |
| 11.54%$156M |
| 7.81%$356M |
| OTEX +3.7pp |
No shared counterparties.